Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Srax Inc (SRAX)

Srax Inc (SRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Joseph Gunnar to Sponsor the Sequire Investor Summit in Puerto Rico

Joseph Gunnar & Co., LLC ("JGUN"), a leading full service broker-dealer, investment adviser and investment bank, focused on the emerging growth markets, is proud to announce its sponsorship of the upcoming...

SRAX : 0.0600 (unch)
SRAX Announces Lineup of Prominent Speakers at the Sequire Investor Summit: Puerto Rico

Los Angeles, California--(Newsfile Corp. - March 21, 2023) - SRAX, Inc. (OTC: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS...

SRAX : 0.0600 (unch)
SRAX Announces Appointment of New CFO

Los Angeles, California--(Newsfile Corp. - March 20, 2023) - SRAX, Inc. (NASDAQ: SRAX), a leading financial technology company, has announced the appointment of Alan Urban as the CFO of SRAX. Mr. Urban...

SRAX : 0.0600 (unch)
SRAX Reassures Investors of Business Health Amid Delisting Notice

Los Angeles, California--(Newsfile Corp. - March 9, 2023) - SRAX, Inc. (NASDAQ: SRAX), a financial technology company that provides data and insights to publicly traded companies through its SaaS platform...

SRAX : 0.0600 (unch)
SRAX Receives Delisting Notice from NASDAQ

Los Angeles, California--(Newsfile Corp. - March 8, 2023) - SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS...

SRAX : 0.0600 (unch)
SRAX Announces Sale of LD Micro to Freedom Holding Corp

Los Angeles, California--(Newsfile Corp. - March 6, 2023) - SRAX, Inc. (NASDAQ: SRAX), a leading financial technology company, has announced the successful sale of its wholly owned subsidiary LD Micro...

SRAX : 0.0600 (unch)
Freedom Holding Acquires LD Micro From SRAX, Inc.

Freedom U.S. Markets, LLC, a wholly-owned subsidiary of Freedom Holding Corp. (NASDAQ: FRHC), announced today that it has completed the acquisition of LD Micro from SRAX, Inc. (NASDAQ: SRAX). The total...

FRHC : 116.22 (-0.25%)
SRAX : 0.0600 (unch)
SRAX Announces the Sequire Investor Summit: Puerto Rico

Los Angeles, California--(Newsfile Corp. - February 16, 2023) - SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its...

SRAX : 0.0600 (unch)
SRAX Acquires DNA Holdings Assets

Los Angeles, California--(Newsfile Corp. - February 6, 2023) - SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its...

SRAX : 0.0600 (unch)
SRAX to Host Business Update Conference Call on Tuesday, January 17th, 2023

Los Angeles, California--(Newsfile Corp. - January 9, 2023) - SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its...

SRAX : 0.0600 (unch)

Barchart Exclusives

Buy This Pharma Stock to Bet on the Next Blockbuster Weight-Loss Drug
A shocking study in The Lancet showed that nearly three-quarters of U.S. adults are overweight or obese. Chances are that by 2050, there will be 260 million overweight Americans. We already have GLP-1 drugs, and amylin-based drugs are next. Novo Nordisk's compound, Cagrilintide, will be combined with semaglutide in its next blockbuster drug, CagriSema. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar